RJD Green Inc: RJDG

TULSA, OK (Marketwired – February 22,, 2017) – RJD Green (OTCPK: RJDG) CEO, Ron Brewer, announced today the IOSOFT Division of RJD Green Inc. has reached agreement to provide services and technology platforms to Pluto X, a wholly owned subsidiary of A & G Healthcare,  a premier provider of cost containment services to healthcare providers nationally. Sales & revenues are expected to be initiated in the next month.

After months of development, IOSOFT was chosen to provide “best in class” payment technology to more than ninety TPAs, Health Plans and insurance payers.

Revenue performance, based on historical industry standards, could be greater than $30,000,000 annually.

IOSOFT

IoSoft provides proprietary software for medical billing, Healthcare claims adjudication, automotive warranty payments, and electronic payments between healthcare Payers and Providers, and several other platform developments. Since formation, IOSOFT has been a third-party developer of software and provides IT support for the platforms developed.

Current efforts of IOSOFT are in healthcare payment systems that provide unique payment technologies and services or software that can be integrated with legacy or existing systems of healthcare payers, such as, Blue Cross, Aetna, CIGNA and others.  IOSOFT provides targeted product offerings for healthcare providers, provider networks, physicians and hospitals; and clearinghouse companies such as Relay Health, a McKesson division, and SSI – ClaimsNet.

RJD GREEN INC.

RJD Green is a holding company focused in three divisions, which create high-growth enterprise opportunities while offering diversity of markets. Those being:

RJD Green Healthcare Services Division –  services and technologies reflecting  five-year growth

Earthlinc Environmental  Services Division  – green environmental services and technologies

Silex Holdings Division – specialty construction and industrial manufacturing and installation

For additional information contact, Ron Brewer, CEO at ronb@rjdgreen.com, or at (918) 551-7883 or Douglas Baker, OTC PR Group at corp@otcprgroup.com , or (561) 807-6350.

Forward-looking Statement: 

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.